ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

HOOK HOOKIPA Pharma Inc

0.819
0.009 (1.11%)
After Hours
Last Updated: 15:30:00
Delayed by 15 minutes

Period:

Draw Mode:

Volume 629,616
Bid Price 0.8102
Ask Price 0.82
News -
Day High 0.8495

Low
0.41

52 Week Range

High
1.27

Day Low 0.80
Share Name Share Symbol Market Stock Type
HOOKIPA Pharma Inc HOOK NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.009 1.11% 0.819 15:30:00
Open Price Low Price High Price Close Price Previous Close
0.80 0.80 0.8495 0.819 0.81
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
1,233 629,616 US$ 0.814056 US$ 512,543 - 0.41 - 1.27
Last Trade Type Quantity Price Currency
15:21:32 1 US$ 0.8199 USD

HOOKIPA Pharma Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
68M 83.95M - 20.13M -81.58M -0.97 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

HOOKIPA Pharma News

Date Time Source News Article
6/04/202415:15Edgar (US Regulatory)Form 8-K - Current report
6/04/202412:00GlobeNewswire Inc.HOOKIPA Pharma Announces Updated Phase 2 Clinical Data at..
5/30/202415:30GlobeNewswire Inc.HOOKIPA Pharma to Host Investor Call on HB-200 Data..
5/23/202416:05Edgar (US Regulatory)Form 8-K - Current report
5/23/202416:01GlobeNewswire Inc.HOOKIPA Pharma Announces Positive Clinical Data to be..
5/09/202406:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/09/202406:03Edgar (US Regulatory)Form 8-K - Current report
5/09/202406:01GlobeNewswire Inc.HOOKIPA Pharma Reports First Quarter 2024 Financial..
4/25/202406:01GlobeNewswire Inc.HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for..
4/24/202406:01GlobeNewswire Inc.HOOKIPA Pharma Announces FDA Clearance of its..
4/16/202415:30GlobeNewswire Inc.HOOKIPA Pharma Announces Grant of Inducement Award Under..
4/10/202406:01GlobeNewswire Inc.HOOKIPA Pharma to Host Investor Call on HB-200 and Planned..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No HOOK Message Board. Create One! See More Posts on HOOK Message Board See More Message Board Posts

Historical HOOK Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.76660.9090.760.8198736666,4900.05246.84%
1 Month0.811.050.730.8535464804,7670.0091.11%
3 Months0.68311.050.680.8327625881,6350.135919.89%
6 Months0.5841.130.540.8188341,671,5330.23540.24%
1 Year1.191.270.410.79896891,115,877-0.371-31.18%
3 Years17.0018.330.411.831,241,036-16.18-95.18%
5 Years7.7920.000.412.36781,659-6.97-89.49%

HOOKIPA Pharma Description

HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.

Your Recent History

Delayed Upgrade Clock